phase iv clinical trials OverviewReal World Perspective. World Class Leadership.PharmaNet's Phase IV leaders help world class companies bridge the gap from development to commercialization. The key is recognizing that Phase IIIb/IV research is undertaken for different reasons than pre-approval studies. Indeed, post-approval success is achieved through documentation and persuasive demonstration of safety and value. And through an operational approach that reflects the unique characteristics of Phase IV: different goals, different measures, different stakeholders, and different timeframes. At PharmaNet, we strive to ensure our clients' Phase IV initiatives achieve both strategic and scientific objectives by leveraging our unique perspectives and global resources. With expertise in Observational (non-interventional) Research and Patient Registries, Interventional IIIb/IV studies and Endpoint programs, Health Economics and Outcomes Research, and Risk Management and Epidemiology, PharmaNet's Phase IV team capabilities span the full spectrum of needs. Of critical importance, we have unique perspective and insight into the organizational dynamics that can make or break a Phase IV initiative, and are regularly called on to provide leadership, vision, and training. This added dimension has enabled our clients to achieve consensus and clarity and highly effective Phase IV initiatives - that often commence well before product approval. Our goal is to support our clients in achieving both commercial and scientific success through a balanced and operationally cost-efficient approach that recognizes the unique attributes of the post-approval landscape. Our services span the spectrum of capabilities to support documentation and demonstration of "real world" safety and value. Clinical Performance
Health Economics and Outcome Research
Risk Management and Epidemiology
In Phase IV research, PharmaNet works for you. |
|
